Literature DB >> 5058970

Inhibition of mammary tumorigenesis by ergot alkaloids and promotion of mammary tumorigenesis by pituitary isografts in adreno-ovariectomized mice.

R Yanai, H Nagasawa.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5058970

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  6 in total

1.  The stability of events in the natural history of neoplasia.

Authors:  H C Pitot
Journal:  Am J Pathol       Date:  1977-12       Impact factor: 4.307

2.  Breast cancer in a male patient with prolactinoma.

Authors:  S Haga; O Watanabe; T Shimizu; T Iida; H Imamura; T Kajiwara; M Fujibayashi
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

Review 3.  Prolactin-lowering and -releasing drugs. Mechanisms of action and therapeutic applications.

Authors:  E E Müller; V Locatelli; S Cella; A Peñalva; A Novelli; D Cocchi
Journal:  Drugs       Date:  1983-04       Impact factor: 9.546

4.  Prolactin effects on the dietary regulation of mouse mammary tumor virus proviral DNA expression.

Authors:  N Hamada; R W Engelman; Y Tomita; R F Chen; H Iwai; R A Good; N K Day
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

5.  Circulating levels of prolactin in human breast cancer.

Authors:  N A Sheth; K J Ranadive; J N Suraiya; A R Sheth
Journal:  Br J Cancer       Date:  1975-08       Impact factor: 7.640

6.  Effect of prolactin and bromocriptine on growth of transplanted hormone-dependent mouse mammary tumours.

Authors:  P Briand; S M Thorpe; J L Daehnfeldt
Journal:  Br J Cancer       Date:  1977-06       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.